Madrigal Pharmaceuticals Inc (MDGL) Transcripts
Q3 2024 Madrigal Pharmaceuticals Inc Earnings Call Transcript
Oct 31, 2024
$259.34
(+20.10%)
Earnings
Q2 2024 Madrigal Pharmaceuticals Inc Earnings Call Transcript
Aug 07, 2024
$234.08
(-12.18%)
Earnings
Q1 2024 Madrigal Pharmaceuticals Inc Earnings Call Transcript
May 07, 2024
$217.96
(-7.48%)
Earnings
Madrigal Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2024
Madrigal Pharmaceuticals Inc at UBS BioPharma Conference Transcript
Nov 08, 2023
Madrigal Pharmaceuticals Inc Phase 3 MAESTRO-NASH Trial Investor Call Transcript
Jun 24, 2023
Madrigal Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript
Jun 13, 2023
Madrigal Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Jun 07, 2023
Madrigal Pharmaceuticals Inc at JMP Securities Life Sciences Conference Transcript
May 16, 2023
Madrigal Pharmaceuticals Inc to Announce Topline Data from the Phase 3 MAESTRO-NASH Study of Resmetirom Presentation Transcript
Dec 19, 2022
Madrigal Pharmaceuticals Inc EASL Investor Event Call Transcript
Jun 25, 2022
Madrigal Pharmaceuticals Inc at JMP Securities Life Sciences Conference Transcript
Jun 15, 2022
Madrigal Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 14, 2022
Madrigal Pharmaceuticals Inc at UBS Global Healthcare Conference Transcript
May 24, 2022
Q1 2022 Madrigal Pharmaceuticals Inc Earnings Call Transcript
May 09, 2022
$58.04
(-10.14%)
Earnings
Madrigal Pharmaceuticals Inc Call to Discuss MAESTRO-NAFLD-1 Phase 3 Data Transcript
Jan 31, 2022
Madrigal Pharmaceuticals Inc AASLD The Liver Meeting Call Transcript
Nov 16, 2021
Madrigal Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021
Madrigal Pharmaceuticals Inc at UBS Global Healthcare Virtual Conference Transcript
May 24, 2021
Madrigal Pharmaceuticals Inc at UBS Global Healthcare Conference (Virtual) Transcript
May 19, 2020